SNAP-8
Anti-Aging & Longevity

SNAP-8

$107.00

Per vial
$10.70
10 vials per pack
Suggested retail
$32.10
3× markup · per vial
Free shipping on orders over $2,000
$300 store credit on any independent COA · results don't matter
  • Delivery guarantee Reshipped free if it doesn't arrive
  • ≥99% purity Manufacturer-direct production
  • Store credit guarantee Send any COA result, get store credit

SNAP-8 - Acetyl Octapeptide-3 Topical Research Peptide

SNAP-8 (acetyl octapeptide-3, also called acetyl glutamyl heptapeptide-1) is a synthetic 8-amino-acid peptide designed to mimic the N-terminus of SNAP-25, a protein component of the SNARE complex that mediates neurotransmitter release at the neuromuscular junction. It was developed specifically as a topical cosmetic research peptide - an extended analog of Argireline (acetyl hexapeptide-3), with two additional residues intended to improve SNARE-complex binding affinity. In research, SNAP-8 is the reference “SNARE-competitive” cosmetic research peptide and is studied almost exclusively in topical formulations targeting expression-line endpoints.

Why the SNAP-25 Mimetic Structure Matters

Muscle contraction requires neurotransmitter release across the neuromuscular junction. That release depends on the SNARE complex - a three-protein assembly (SNAP-25, syntaxin, VAMP) that docks acetylcholine-containing vesicles to the presynaptic membrane. SNAP-8 is engineered to compete with native SNAP-25 for assembly into the complex. When it binds, the complex is incomplete and vesicle docking is impaired. That mechanism is the same axis botulinum toxin targets - but by different means (toxin cleaves SNAP-25; SNAP-8 competes with it). The research distinction is why SNAP-8 shows up in “topical alternative to neuromuscular-blocker” cosmetic research.

Pathway What it does in plain terms
SNARE complex Competitive inhibition - SNAP-8 mimics SNAP-25 and disrupts complex assembly
Acetylcholine release Reduced at the neuromuscular junction in published in vitro work
Expression-line endpoints Reduced mimetic-muscle contraction in topical cosmetic research
Route of application Topical - penetration limited by peptide size and formulation vehicle

SNAP-8 vs Argireline

The two compounds are compared constantly in cosmetic peptide research. SNAP-8 is an extension of the Argireline structure.

Compound Structural difference
SNAP-8 8 amino acids - extended SNAP-25 N-terminus analog
Argireline (Acetyl Hexapeptide-3) 6 amino acids - shorter SNAP-25 N-terminus analog (the parent compound)

Research Applications

SNAP-8 is used in studies examining:

  • SNARE-complex competitive inhibition endpoints
  • Topical expression-line cosmetic formulation research
  • Acetylcholine-release in vitro research at the neuromuscular junction
  • Comparative cosmetic peptide research (SNAP-8 vs Argireline)
  • Non-injectable alternative mechanism research vs neuromuscular-blocking toxins
  • Peptide penetration and formulation-vehicle research

Specifications
Format Lyophilized powder
Purity ≥99%
Aliases SNAP-8, Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-1
Available sizes 10mg
Storage 2-8°C unopened; stable 12+ months
Use Research purposes only - not for human use

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for SNAP-8 are documented in the published peer-reviewed literature and standard peptide-chemistry references.

Reference Literature

Published clinical and preclinical SNAP-8 literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.

Common Questions About SNAP-8 Research

What is SNAP-8 used for in research?

It is studied as the reference SNARE-complex competitive research peptide. Published work covers topical expression-line cosmetic formulation endpoints, acetylcholine-release in vitro research, and comparative cosmetic peptide research against Argireline.

What is the difference between SNAP-8 and Argireline?

SNAP-8 is an 8-amino-acid extension of Argireline (acetyl hexapeptide-3, 6 amino acids). Both are SNAP-25 N-terminus mimetics that competitively disrupt SNARE-complex assembly. SNAP-8 was designed with two additional residues intended to improve SNARE-complex binding affinity. In cosmetic research literature, SNAP-8 is often marketed as “second-generation Argireline.”

Is SNAP-8 the same mechanism as botulinum toxin?

Both target the SNARE complex, but through different mechanisms. Botulinum toxin is a protease that enzymatically cleaves SNAP-25. SNAP-8 is a small peptide that competes with SNAP-25 for assembly into the SNARE complex. The toxin destroys the protein; the peptide blocks its assembly. Research framing treats them as axis-related but mechanistically distinct.

Is SNAP-8 FDA approved?

No. SNAP-8 is not an FDA-approved drug product. It is an ingredient used in cosmetic research formulations. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is SNAP-8 stored?

Unopened vials are stored at 2-8°C and stay stable for 12+ months. Once reconstituted or incorporated into a topical vehicle, store at 2-8°C and use within 28-30 days.

Purity Guarantee

Every batch is ≥99% purity. Send us a COA from any independent test and we’ll issue store credit regardless of what it shows.

You might also like View all products →